BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18344976)

  • 1. Expression of prostate-specific membrane antigen in renal cortical tumors.
    Al-Ahmadie HA; Olgac S; Gregor PD; Tickoo SK; Fine SW; Kondagunta GV; Scher HI; Morris MJ; Russo P; Motzer RJ; Reuter VE
    Mod Pathol; 2008 Jun; 21(6):727-32. PubMed ID: 18344976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms.
    Baccala A; Sercia L; Li J; Heston W; Zhou M
    Urology; 2007 Aug; 70(2):385-90. PubMed ID: 17826525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Evaluation of Prostate Specific Membrane Antigen Expression in the Vasculature of Renal Tumors: Implications for Imaging Studies and Prognostic Role.
    Spatz S; Tolkach Y; Jung K; Stephan C; Busch J; Ralla B; Rabien A; Feldmann G; Brossart P; Bundschuh RA; Ahmadzadehfar H; Essler M; Toma M; Müller SC; Ellinger J; Hauser S; Kristiansen G
    J Urol; 2018 Feb; 199(2):370-377. PubMed ID: 28827104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma.
    Mazal PR; Exner M; Haitel A; Krieger S; Thomson RB; Aronson PS; Susani M
    Hum Pathol; 2005 Jan; 36(1):22-8. PubMed ID: 15712178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma.
    Osunkoya AO; Cohen C; Lawson D; Picken MM; Amin MB; Young AN
    Hum Pathol; 2009 Feb; 40(2):206-10. PubMed ID: 18799195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.
    Chang SS; Reuter VE; Heston WD; Bander NH; Grauer LS; Gaudin PB
    Cancer Res; 1999 Jul; 59(13):3192-8. PubMed ID: 10397265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Well-Differentiated Thyroid Cancer Neovasculature Expresses Prostate-Specific Membrane Antigen-a Possible Novel Therapeutic Target.
    Moore M; Panjwani S; Mathew R; Crowley M; Liu YF; Aronova A; Finnerty B; Zarnegar R; Fahey TJ; Scognamiglio T
    Endocr Pathol; 2017 Dec; 28(4):339-344. PubMed ID: 28844117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
    Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
    Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis.
    Osunkoya AO; Yin-Goen Q; Phan JH; Moffitt RA; Stokes TH; Wang MD; Young AN
    Hum Pathol; 2009 Dec; 40(12):1671-8. PubMed ID: 19695674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the Na+/K+-transporting ATPase gamma subunit FXYD2 in renal tumors.
    Gaut JP; Crimmins DL; Lockwood CM; McQuillan JJ; Ladenson JH
    Mod Pathol; 2013 May; 26(5):716-24. PubMed ID: 23196795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of MUC1 (EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases.
    Langner C; Ratschek M; Rehak P; Schips L; Zigeuner R
    Mod Pathol; 2004 Feb; 17(2):180-8. PubMed ID: 14657952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the glucocorticoid receptor in renal cell neoplasms: an immunohistochemical and quantitative reverse transcriptase polymerase chain reaction study.
    Yakirevich E; Matoso A; Sabo E; Wang LJ; Tavares R; Meitner P; Morris DJ; Pareek G; Delellis RA; Resnick MB
    Hum Pathol; 2011 Nov; 42(11):1684-92. PubMed ID: 21531004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
    Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M
    Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXI1 expression in chromophobe renal cell carcinoma and renal oncocytoma: a study of The Cancer Genome Atlas transcriptome-based outlier mining and immunohistochemistry.
    Tong K; Hu Z
    Virchows Arch; 2021 Apr; 478(4):647-658. PubMed ID: 32812119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic utility of S100A1, GLUT-1 and Caveolin-1 in renal tumors with oncocytic features: a comparative study].
    Zhang W; Wang K; Yu W; Liu Y; Chu J; Jiang Y; Li Y
    Zhonghua Bing Li Xue Za Zhi; 2015 Nov; 44(11):767-71. PubMed ID: 26888385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling.
    Hornsby CD; Cohen C; Amin MB; Picken MM; Lawson D; Yin-Goen Q; Young AN
    Arch Pathol Lab Med; 2007 Oct; 131(10):1541-6. PubMed ID: 17922590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of Ksp-cadherin in renal epithelial neoplasm and its clinicopathologic significance].
    Rao Q; Zhou XJ; Shi QL; Yin HL; Ma HH; Zhou HB; Zhang RS
    Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):15-8. PubMed ID: 17374232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic value of EMA expression in the renal parenchyma tumors.
    Alexa A; Baderca F; Lighezan R; Zăhoi DE; Izvernariu D
    Rom J Morphol Embryol; 2011; 52(3 Suppl):1019-25. PubMed ID: 22119819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.